| 88.48 Data as of 3:59pm ET | -0.21 / -0.24%Today’s Change | 63.38 Today|||52-Week Range 90.54 | +23.45% Year-to-Date |
The investment seeks to track the performance of a benchmark index. The fund employs an indexing investment approach designed to track the performance of the MSCI US Investable Market Index (IMI)/Health Care 25/50, an index made up of stocks of large, mid-size, and small U.S. companies within the health care sector, as classified under the Global Industry Classification Standard (GICS). It attempts to replicate the target index by investing all, or substantially all, of its assets in the stocks that make up the index, holding each stock in approximately the same proportion as its weighting in the index. The fund is non-diversified.
| Notable ETF Inflow Detected - VHT, JNJ, LLY, UNH May 16 / TheStreet.com |
| 1 month | +3.59% | 3 years | +22.25% | |
| 3 months | +14.42% | 5 years | +12.29% | |
| 1 year | +37.72% | Since inception | +7.68% |
| Previous close | $88.69 |
| Open day’s range | 88.14 – 90.54 |
| Net asset value (NAV) | 88.65 (05/21/2013) |
| Daily volume | 245,322 |
| Average volume (3 months) | 158,615 |
| VHT | Category | |
|---|---|---|
| Performance 5-yr return | +12.29% | +13.03% |
| Expense Gross exp ratio | 0.14% | 0.47% |
| Risk 5 year sharpe ratio | 0.74 | 0.75 |
| Net assets | $1.8B | $776.1M |
| Average market cap | $36.4B | $19.4B |
| Average P/E | 19.3 | 21.6 |
| Dividend / Share | -- | 0.22% |
| XLV Health Care Select Sector SPDR Fund |
| IXJ iShares S&P Global Healthcare Index Fund |
| IYH iShares Dow Jones US Healthcare Sector I... |
| Healthcare | 97.05% |
| Hardware | 1.62% |
| Business service | 0.22% |
| Financial service | 0.05% |
| Consumer service | 0.02% |
| JNJ Johnson & Johnson | 10.73% |
| PFE Pfizer Inc | 10.09% |
| MRK Merck & Co Inc | 6.39% |
| AMGN Amgen Inc | 3.74% |
| GILD Gilead Sciences Inc | 3.52% |
| BMY Bristol-Myers Squibb Company | 3.23% |
| ABBV AbbVie Inc | 3.04% |
| LLY Eli Lilly and Company | 2.82% |
| UNH UnitedHealth Group Inc | 2.78% |
| ABT Abbott Laboratories | 2.65% |